{
    "nctId": "NCT00575744",
    "briefTitle": "Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation",
    "officialTitle": "Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 699,
    "primaryOutcomeMeasure": "To continue gathering data relating to the sentinel lymph node biopsy procedure.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer requiring lymph node evaluation\n* Clinically negative lymph nodes in the axilla\n* Willing participation following an informed consent process\n\nExclusion Criteria:\n\n* Patients with clinically positive lymph nodes\n* Pregnancy (if a pregnant female should be diagnosed with breast cancer an exception would be considered on a case to case basis)\n* Previous axillary lymphadenectomy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}